Tortoise Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Tortoise Investment Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,267	Closed	-$40K	–	790
2022 Q2	$40K	Hold	1,267	–	–	0.01%	332
2022 Q1	$44K	Hold	1,267	–	–	0.01%	327
2021 Q4	$37K	Hold	1,267	–	–	0.01%	329
2021 Q3	$32K	Hold	1,267	–	–	0.01%	326
2021 Q2	$44K	Hold	1,267	–	–	0.01%	288
2021 Q1	$52K	Hold	1,267	–	–	0.01%	255
2020 Q4	$55K	Hold	1,267	–	–	0.01%	233
2020 Q3	$70K	Hold	1,267	–	–	0.02%	204
2020 Q2	$80K	Hold	1,267	–	–	0.02%	194
2020 Q1	$65K	Hold	1,267	–	–	0.02%	202
2019 Q4	$101K	Hold	1,267	–	–	0.02%	190
2019 Q3	$61K	Hold	1,267	–	–	0.02%	219
2019 Q2	$67K	Hold	1,267	–	–	0.02%	220
2019 Q1	$67K	Hold	1,267	–	–	0.02%	219
2018 Q4	$52K	Hold	1,267	–	–	0.01%	231
2018 Q3	$48K	Hold	1,267	–	–	0.01%	243
2018 Q2	$57K	Sell	1,267 -640	-34%	-$29.1K	0.02%	237
2018 Q1	$92K	Hold	1,907	–	–	0.03%	187
2017 Q4	$75K	Hold	1,907	–	–	0.02%	205
2017 Q3	$59K	Hold	1,907	–	–	0.02%	211
2017 Q2	$52K	Hold	1,907	–	–	0.02%	213
2017 Q1	$70K	Hold	1,907	–	–	0.02%	173
2016 Q4	$28K	Hold	1,907	–	–	0.01%	241
2016 Q3	$44K	Hold	1,907	–	–	0.01%	206
2016 Q2	$32K	Sell	1,907 -950	-33%	-$19.2K	0.01%	233
2016 Q1	$45K	Buy	+2,857	New	+$50.8K	0.02%	204

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Tortoise Investment Management's GBT Position: Q3 2022 in Review

Tortoise Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 1,267 shares — an estimated $40K sold.

Tortoise Investment Management first reported a position in GBT in Q1 2016 and held it in 26 quarters. The position peaked at $101K in Q4 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

Tortoise Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
Tortoise Investment Management sold 1,267 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $40K.
Tortoise Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 26 quarters.
Tortoise Investment Management's Global Blood Therapeutics, Inc. position peaked at $101K in Q4 2019.
247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Tortoise Investment Management's 13F filing for Q3 2022, filed 4 Nov 2022.